Alector Inc
$ 2.19
4.29%
24 Feb - close price
- Market Cap 229,218,000 USD
- Current Price $ 2.19
- High / Low $ 2.23 / 2.06
- Stock P/E N/A
- Book Value 0.54
- EPS -1.06
- Next Earning Report 2026-02-25
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.18 %
- ROE -1.22 %
- 52 Week High 3.40
- 52 Week Low 0.87
About
Alector, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of neurodegenerative diseases. The company is headquartered in South San Francisco, California.
Analyst Target Price
$2.10
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-07 | 2025-05-06 | 2025-02-25 | 2024-11-05 | 2024-08-07 | 2024-05-08 | 2024-02-27 | 2023-11-07 | 2023-08-03 | 2023-05-04 | 2023-02-28 |
| Reported EPS | -0.34 | -0.3 | -0.41 | -0.02 | -0.43 | -0.4 | -0.38 | -0.49 | -0.53 | 0.02 | -0.55 | -0.63 |
| Estimated EPS | -0.4 | -0.47 | -0.51 | -0.5443 | -0.53 | -0.5 | -0.51 | -0.77 | -0.66 | -0.82 | -0.76 | -0.46 |
| Surprise | 0.06 | 0.17 | 0.1 | 0.5243 | 0.1 | 0.1 | 0.13 | 0.28 | 0.13 | 0.84 | 0.21 | -0.17 |
| Surprise Percentage | 15% | 36.1702% | 19.6078% | 96.3256% | 18.8679% | 20% | 25.4902% | 36.3636% | 19.697% | 102.439% | 27.6316% | -36.9565% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-25 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.39 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
